HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases

Modern Pathology

Volumn 27, Issue 12, 2014, Pages 1559-1567

  Pirog, Edyta C ^a   Lloveras, Belen ^b   Molijn, Anco ^c   Tous, Sara ^d   Guimerà, Núria ^c   Alejo, Maria ^e   Clavero, Omar ^d   Klaustermeier, Joellen ^d,f   Jenkins, David ^c   Quint, Wim G V ^c   Xavier Bosch, Francesc ^d   Alemany, Laia ^d,f   De Sanjosé, Silvia ^d,f  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOSPITAL DEL MAR   (Spain)

^c Manager Development and Diagnostic Services (DDS)   (Netherlands)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e HOSPITAL GENERAL DE CATALUNYA   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

cervical adenocarcinoma; human papillomavirus

Indexed keywords

PARAFFIN; VIRUS DNA;

ADULT; AGE DISTRIBUTION; ARTICLE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 34; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 43; HUMAN PAPILLOMAVIRUS TYPE 44; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 54; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 74; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIDDLE AGED; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAMPLE STORAGE DURATION; TISSUE SECTION; UTERINE CERVIX CARCINOMA; VACCINATION; WART VIRUS; ADENOCARCINOMA; ADOLESCENT; COMPLICATION; GENETICS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; UTERINE CERVIX TUMOR; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84927178626     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2014.55     Document Type: Article

References (27)

1. de Sanjosé S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010;11:1048-1056.
2. Wells M, Östör AG, Crum CP, et al. Chapter 5: Tumours of the uterine cervix, In: Tavassoli FA, Devilee P (eds). World Health Organization: Tumours of the Breast and Female Genital Organs (WHO/IARC Classification of Tumours) (IARC WHO Classification of Tumours). The International Agency for Research on Cancer: Lyon, France, 2003, pp 259-289.
3. Park JS, Kim YT, Lee A, et al. Prevalence and type distribution of human papillomavirus in cervical adenocarcinoma in Korean women. Gynecol Oncol 2013;130:115-120.
4. Pirog EC, Kleter B, Olgac S, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 2000;157: 1055-1062.
5. Quint KD, de Koning MN, Geraets DT, et al. Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma. Gynecol Oncol 2009;114:390-394.
6. An HJ, Kim KR, Kim IS, et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod Pathol 2005;18:528-534.
7. Zielinski GD, Snijders PJ, Rozendaal L, et al. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. J Pathol 2003;201:535-543.
8. Tenti P, Romagnoli S, Silini E, et al. Human papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix: PCR analysis of 138 cases and correlation with histologic type and grade. Am J Clin Pathol 1996;106:52-56.
9. Castellsagué X, Díaz M, de Sanjosé S, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 2006;98:303-315.
10. Odida M, de Sanjosé S, Sandin S, et al. Comparison of human papillomavirus detection between freshly frozen tissue and paraffin embedded tissue of invasive cervical cancer. Infect Agent Cancer 2010;5:15.
11. Cooper K, Herrington CS, Lo ES, et al. Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma. J Clin Pathol 1992;45:382-384.
12. Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88: 63-73.
13. Park KJ, Kiyokawa T, Soslow RA, et al. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus. Am J Surg Pathol 2011;35:633-646.
14. Houghton O, Jamison J, Wilson R, et al. p16 immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection. Histopathology 2010;57:342-350.
15. Mikami Y, Kiyokawa T, Hata S, et al. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/ pyloric gland metaplasia and 'adenoma malignum'. Mod Pathol 2004;17:962-972.
16. Kuragaki C, Enomoto T, Ueno Y, et al. Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervix. Lab Invest 2003;83: 35-45.
17. Ahrens WA, Barrón-Rodriguez LP, McKee M, et al. Clear cell adenocarcinoma of the cervix in a child without in utero exposure to diethylstilbestrol: a case report and review of the literature. Pediatr Dev Pathol 2005;8:690-695.
18. Kaplan EJ, Caputo TA, Shen PU, et al. Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case. Gynecol Oncol 1998;70:289-294.
19. Nofech-Mozes S, Khalifa MM, Ismiil N, et al. Detection of HPV-DNA by a PCR-based method in formalin-fixed, paraffin-embedded tissue from rare endocervical carcinoma types. Appl Immunohistochem Mol Morphol 2010;18:80-85.
20. Alfsen GC, Reed W, Abeler VM. Reproducibility of classification in non-squamous cell carcinomas of the uterine cervix. Gynecol Oncol 2003;90:282-289.
21. Quint W, Jenkins D, Molijn A, et al. One virus, one lesion-individual components of CIN lesions contain a specific HPV type. J Pathol 2012;227:62-71.
22. Wang SS, Sherman ME, Silverberg SG, et al. Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study. Gynecol Oncol 2006;103: 541-546.
23. Lehtinen M, Dillner J. Clinical trials of human papillomavirus vaccines and beyond. J Nat Rev Clin Oncol 2013;10:400-410.
24. Schiller JT, Castellsagué X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012;30:123-138.
25. Serrano B, Alemany L, Tous S, et al. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agent Cancer 2012; 7:38.
26. Luxembourg A. On behalf of the V503 Program Team Merck: Whitehouse Station, NJ, USA An overview of the 9-valent HPV L1 virus-like particle vaccine clinical development program. EUROGIN: Florence, 2013.
27. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189: 12-19.